Results 51 to 60 of about 1,561,319 (123)

Induction of morphological alterations by antineoplastic agents in yeast.

open access: yes, 2002
Saccharomyces cerevisiae was used as an alternative experimental model in order to investigate the effects of antineoplastic agents on eukaryotic cells.
Stavrinidis, E.   +2 more
core   +1 more source

Approval of antineoplastic agents in India: comparison with the US and EU regions [PDF]

open access: yes, 2017
Background: The antineoplastic drugs are prescribed for the treatment of cancer, which is an important cause of mortality in India; therefore, a drug lag in the availability of antineoplastic drugs is a direct threat to life.
Chhaiya, Sunita B.   +2 more
core  

Antineoplastic agents; occupational hazards in hospitals

open access: yes
"Antineoplastic agents are widely used in cancer therapy because they can inhibit growth by disrupting cell division and killing actively growing cells. These agents can also cause health effects among health care workers who work with them. A summary of

core  

Dendrogenin A and antineoplastic agents for the treatment of chemosensitive or chemoresistant tumors

open access: yes, 2019
Dendrogenin A and antineoplastic agents for the treatment of chemosensitive or chemoresistant tumors. The invention concerns a kit-of-parts comprising 5α-hydroxy-6β-[2-(1H-imidazol-4-yl)ethylamino]cholestan-3β-ol (Dendrogenin A) or a pharmaceutically ...
Silvente-Poirot, Sandrine   +4 more
core   +3 more sources

Hypersensitivity reactions to antineoplastic agents: an overview

open access: yes, 2009
Hypersensitivity reactions to antineoplastic agents are defined as unexpected reactions with signs and symptoms inconsistent with known toxicity of antineoplastic drugs.
Makrilia, Nektaria   +5 more
core  

Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents : updated MASCC/ESMO consensus recommendation [PDF]

open access: yes
Purpose: Our goal was to identify new anticancer agents approved by the US Food and Drug Administration (FDA) and the European Medical Agency (EMA) since the 2016 MASCC/ESMO antiemetic update and classify their emetic potential. Methods: The MASCC/
Jordan, Karin   +7 more
core   +3 more sources

Knowledge, attitudes and beliefs of cypriot nurses on the handling of antineoplastic agents

open access: yes, 2010
Background: Antineoplastic agents have been associated with major concerns among health professionals. The objective of our study was to evaluate the knowledge, attitudes and beliefs of Cypriot nurses on their exposure to antineoplastic agents.
Raftopoulos, Vasilios   +10 more
core   +1 more source

Low molecular weight heparins as antineoplastic agents.

open access: yes, 2008
There is an increasing interest in the potential role of low molecular weight heparins (LMWHs) in the management of cancer patients. These antithrombotic agents have generated particular excitement because they have been proved useful in both the ...
SIRAGUSA, Sergio
core   +1 more source

Adherence to oral antineoplastic agents, an overview and meta-analysis

open access: yes
Background The use of oral antineoplastic therapies has accelerated in recent years. Non-supervised administration of oncological therapies introduces uncertainty in regard to adherence.
Fohlin, Helena   +3 more
core   +1 more source

Pulmonary toxicity from novel antineoplastic agents

open access: yes, 2006
Background: The pulmonary side-effects induced by novel antineoplastic agents have not been well characterized. Methods: To further investigate this topic, relevant English and non-English language studies were identified through Medline.
Bamias, A   +3 more
core  

Home - About - Disclaimer - Privacy